HOPE Therapeutics and NRx Pharmaceuticals Announce Major Step in Transforming Mental Health Care with Kadima Institute Acquisition The acquisition of Kadima Neuropsychiatry Institute marks a landmark development for HOPE Therapeutics aimed at revolutionizing mental health treatment through cutting-edge methodologies.

HOPE Therapeutics and NRx Pharmaceuticals Announce Major Step in Transforming Mental Health Care with Kadima Institute Acquisition #USA #NRx_Pharmaceuticals #La_Jolla #Hope_Therapeutics #Kadima_Institute